|
Volumn 146, Issue 2, 2002, Pages 336-337
|
Treatment of erythromelalgia with a serotonin/noradrenaline reuptake inhibitor [5]
a b c d |
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
AMITRIPTYLINE;
BENZODIAZEPINE DERIVATIVE;
GABAPENTIN;
NORADRENALIN;
NORADRENALIN UPTAKE INHIBITOR;
OPIATE DERIVATIVE;
SEROTONIN;
SEROTONIN UPTAKE INHIBITOR;
VENLAFAXINE;
ANXIETY NEUROSIS;
ARTERIOVENOUS SHUNT;
CLINICAL ARTICLE;
CLINICAL FEATURE;
CONTROLLED STUDY;
DEPRESSION;
DISEASE SEVERITY;
DRUG ACTIVITY;
DRUG EFFECT;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERANCE;
ERYTHROMELALGIA;
EVALUATION;
HISTOPATHOLOGY;
HUMAN;
LETTER;
MYELOPROLIFERATIVE DISORDER;
NAUSEA;
OBSESSION;
PAIN;
PRIORITY JOURNAL;
RAYNAUD PHENOMENON;
SEROTONIN UPTAKE;
SHEAR STRESS;
SKIN BIOPSY;
SOMNOLENCE;
SYMPATHETIC INNERVATION;
THROMBOCYTE FUNCTION;
XEROSTOMIA;
CYCLOHEXANOLS;
ERYTHROMELALGIA;
HUMANS;
PILOT PROJECTS;
SEROTONIN UPTAKE INHIBITORS;
|
EID: 0036202544
PISSN: 00070963
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1365-2133.2002.4653_6.x Document Type: Letter |
Times cited : (12)
|
References (10)
|